This inventor holds 2 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Agency for Science, Technology and Research, Nanyang Technological University, Novartis Ag. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 2022-2026
Title: Shuyi Pearly Ng: Innovator in Parasitic Disease Treatment
Introduction
Shuyi Pearly Ng is a notable inventor based in Singapore, recognized for his contributions to the field of pharmaceutical sciences. His innovative work focuses on developing compounds that can effectively treat parasitic diseases. With a strong background in research and development, Ng has made significant strides in the medical field.
Latest Patents
Ng holds a patent for "5,6-fused-bicyclic compounds and compositions for the treatment of parasitic diseases." This invention provides a compound of Formula (I) or a pharmaceutically acceptable salt thereof. It also includes a method for manufacturing these compounds and outlines their therapeutic uses. Furthermore, the invention presents a combination of pharmacologically active agents and a pharmaceutical composition.
Career Highlights
Shuyi Pearly Ng is currently employed at Novartis AG, a leading global healthcare company. His role involves extensive research and development aimed at creating innovative solutions for health challenges. Ng's dedication to his work has led to the successful patenting of his research findings.
Collaborations
Ng collaborates with esteemed colleagues, including Jan Jiricek and Isabelle K Lerario, who contribute to his research endeavors. Their combined expertise enhances the potential for groundbreaking discoveries in the treatment of parasitic diseases.
Conclusion
Shuyi Pearly Ng's innovative work in developing compounds for treating parasitic diseases showcases his commitment to advancing medical science. His contributions are vital in the ongoing fight against these health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile